Lior Greenbaum

Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia

Cornelis Blauwendraat, Xylena Reed, Lynne Krohn et al. · Brain · 2019 · 245 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Green Fluorescent Protein Photobleaching: a Model for Protein Damage by Endogenous and Exogenous Singlet Oxygen

Lior Greenbaum, Chana Rothmann, Ronit Lavie et al. · Biological Chemistry · 2000 · 134 citations

Life Sciences, Cell Biology, Molecular Biology +16

<i>SMPD1</i> mutations, activity, and α‐synuclein accumulation in Parkinson's disease

Roy N. Alcalay, Victoria Mallett, Benoît Vanderperre et al. · Movement Disorders · 2019 · 115 citations · Full text

Life Sciences, Molecular Genetics, Neurology +17

Genetic, Structural, and Functional Evidence Link <i>TMEM175</i> to Synucleinopathies

Lynne Krohn, Tuǧba N. Öztürk, Benoît Vanderperre et al. · Annals of Neurology · 2019 · 107 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations

Gilad Yahalom, Lior Greenbaum, Simon Israeli‐Korn et al. · Parkinsonism & Related Disorders · 2018 · 104 citations

Life Sciences, Genetics, Neurology +15